A.R.T. Advisors, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 118 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$20,000
-90.9%
10,799
-90.8%
0.03%
+172.7%
Q3 2019$220,000
-48.8%
117,577
-28.6%
0.01%
-54.2%
Q2 2019$430,000
+98.2%
164,677
+95.2%
0.02%
+84.6%
Q1 2019$217,000
-48.3%
84,377
-53.8%
0.01%
-51.9%
Q4 2018$420,000
-28.1%
182,502
+0.3%
0.03%0.0%
Q3 2018$584,000
-51.7%
181,938
-57.4%
0.03%
-44.9%
Q2 2018$1,209,000
+351.1%
427,362
+463.8%
0.05%
+345.5%
Q1 2018$268,000
+587.2%
75,800
+389.0%
0.01%
+450.0%
Q3 2017$39,000
-56.7%
15,500
-53.2%
0.00%
-60.0%
Q2 2017$90,000
-32.8%
33,100
-45.0%
0.01%
-28.6%
Q2 2016$134,000
-44.6%
60,151
-48.5%
0.01%
-36.4%
Q1 2016$242,000
-36.1%
116,784
-6.7%
0.01%
-38.9%
Q4 2015$379,000
+58.6%
125,184
+29.3%
0.02%
+100.0%
Q3 2015$239,000
-33.6%
96,784
-13.5%
0.01%
-25.0%
Q2 2015$360,000
+531.6%
111,884
+345.1%
0.01%
+500.0%
Q4 2014$57,000
+23.9%
25,137
+5.1%
0.00%0.0%
Q3 2014$46,000
-90.1%
23,920
-85.4%
0.00%
-92.0%
Q4 2013$466,000
+11.0%
163,627
+39.5%
0.02%
+8.7%
Q3 2013$420,000
-42.5%
117,327
-46.4%
0.02%
-4.2%
Q2 2013$730,000218,7180.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,020,719$3,746,0002.58%
Boxer Capital, LLC 1,351,137$4,959,0002.22%
Palo Alto Investors LP 5,186,088$19,033,0001.11%
DAFNA Capital Management LLC 340,000$1,248,0000.87%
SENZAR ASSET MANAGEMENT, LLC 907,203$3,329,435,0000.86%
Rhenman & Partners Asset Management AB 1,400,000$5,138,000,0000.82%
NEA Management Company, LLC 3,243,150$11,902,0000.53%
Cormorant Asset Management, LP 1,155,600$4,241,0000.47%
Ghost Tree Capital, LLC 700,000$2,569,0000.42%
Rock Springs Capital Management LP 1,810,000$6,643,0000.42%
View complete list of RIGEL PHARMACEUTICALS INC shareholders